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RESUMEN
Este trabajo se enfoca en el problema de acoplamiento molecular (docking), el cual
es de gran intere´s para las a´reas de quimioinforma´tica y disen˜o racional de fa´r-
macos. Ba´sicamente, el problema de docking consiste en predecir e identificar los
complejos ma´s estables formados entre una macromole´cula como DNA, RNA o una
prote´ına (denominada receptor) y una mole´cula orga´nica pequen˜a (denominada lig-
ando). Aunque, desde inicios de los 80 hasta la actualidad se han dedicado grandes
esfuerzos para resolver el problema de docking, este sigue siendo un problema de-
safiante y varios aspectos au´n no han sido satisfactoriamente resueltos.
Esta tesis propone un modelo de optimizacio´n multi-objetivo de prediccio´n de com-
plejos prote´ına–ligando, basado en las contribuciones energe´ticas debidas a la inter-
accio´n molecular. El modelo se evaluo´ con un set de complejos de referencia, que
han sido ampliamente utilizados en la validacio´n y evaluacio´n de otros modelos de
docking; estos complejos se encuentran en la base de datos del protein data bank
(PDB), identificados como: 1ABE, 1CDG, 1ACM y 1BAF. Los resultados obtenidos
muestran que el modelo es flexible en cuanto al uso de algoritmos de optimizacio´n y
funciones de energ´ıa; adicionalmente, predice las ubicaciones y conformaciones del
ligando en el sitio de unio´n del receptor de forma tal que los complejos obtenidos
son energe´ticamente estables.
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ABSTRACT
This work focuses on the docking problem, which is one of the most important
problems in chemoinformatics and drug design. Basically, it deals with the prediction
and identification of the most stable complexes formed between a macromolecule
such as DNA, RNA or a protein (namely the receptor) and a small organic molecule
(called the ligand). Although a great deal of work has been carried out since the late
eighties to solve the docking problem, it is still very challenging and several issues
have not yet been solved.
This thesis proposes a multi-objective model for predicting protein–ligand complexes
based on the energetic contributions that occur in molecular interactions. The per-
formance of the model was evaluated over a set of benchmark complexes that have
been widely used in the validation and evaluation of other docking models; these
complexes are reported in the protein data bank (PDB) as: 1ABE, 1CDG, 1ACM,
and 1BAF. The results show that the proposed model is flexible to the use of differ-
ent search algorithms and energy functions; it predicts ligand localizations on the
receptor binding site and the ligand conformations that form adequate complexes
with the receptor.
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Chapter 1
INTRODUCTION
Molecular interactions that take place within living organisms are complex and in-
volve many different molecules. A simplified way of seeing them is to consider a
receptor–ligand system, where the receptor is a macromolecule involved in a spe-
cific biochemical pathway of a target organism, and the ligand is a molecule that
binds to such receptor, affecting its functioning. Different types of macromolecules
such as DNA, RNA and proteins, are considered receptors. Among them, proteins
account for the largest percentage of receptors that are of pharmacological interest
mainly due to their abundance and importance in biochemical pathways. In turn,
many different types of molecules can act as ligands, including proteins, peptides
(molecules made up by a few amino acids) and small organic molecules of exoge-
nous or endogenous origin. Both the receptor and the ligand are embedded in a
particular environment, which consists of water molecules, ions, ligands and several
other different molecules that can affect the interaction between both molecules. In
summary, molecular interactions can be represented as dynamic systems where all
molecules are continuously moving.
Predicting the structures that may result from the interaction of a receptor and a
ligand (known as the docking problem) is of special interest in drug design given
that the ligand can affect the behavior of the receptor. In other words, if the
malfunctioning of a receptor that is involved in a specific pathway and is associated
to a particular disease, is “restored” by binding a particular ligand, then such ligand
can be considered a potential drug.
1
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Thanks to the development of techniques to elucidate the structural conformation
of a molecule inside living organisms and to the wide accessibility to these data,
a rational drug development process has become possible by driving drug research
toward the identification of the structures that need to be attacked in a specific
illness; this prevents wasting time and resources in molecules of improbable phar-
macological activity. In consequence, the inclusion of structural information has
transformed drug development from a trial-and-error experimentation process into
a rational drug design process to discover new drugs [8, 49].
Several computational tools have been developed in an attempt to solve the docking
problem and hence reduce the number of ligands to be evaluated in vivo by focusing
on those with the ability to bind to the receptor involved in the disease of interest.
Nevertheless, modeling biological systems is not a trivial task. It demands making
different simplifications and assumptions either to simulate the binding process or
to select the molecules that will bind to the receptor. Among such simplifications,
those that have had important implications on the results of the predictions are the
ones made over the dynamics of the system and the interaction energies that are
considered in the simulation of the binding process [86, 13].
One of the strongest simplifications regarding the system dynamics consists in con-
sidering structures as rigid bodies. Under this simplification, the ability of the model
to predict the protein–ligand structure is drastically reduced, as mentioned by Tro-
tov et al. in their 2008 study where they report that “docking algorithms predict an
incorrect binding pose for about 50 to 70% of all ligands when only a single fixed
receptor conformation is considered” [89]. When the model considers both the recep-
tor and the ligand as flexible structures, the effectiveness of the prediction increases
to 71% [46, 27].
On the other hand, the energetic implications of the interaction are simplified when
the docking model uses scoring functions to evaluate energy changes in the binding
interface. One type of scoring functions are force field (FF) scoring functions. These
functions must assign atom types to evaluate the interactions that occur between
the two molecules. Atom types are assigned based on the nature of the atom it-
self, the number of covalent bonds and its neighbor atoms [91]; however, since it
is impossible to identify the amount of atom types in all organic molecules, certain
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degree of generalization is needed in order to assign the atom types; however, such
overgeneralization introduces an error to the obtained energy value. There are other
examples of this kind of simplifications or assumptions; but they are not described
here as they are beyond the scope of this work. As a result of energetic simplifica-
tions, there is low correlation between experimentally obtained energy values and
computed energy values. The scoring functions have been subjected to continous
optimization and novel approaches have been proposed to improve the results, but
still predictions are not good enough [68, 93].
In general terms, although the docking problem has been widely explored and studied
over the years, it still is an open problem. This work aims to propose a computational
model to face both of the issues mentioned above, namely, the system dynamics and
energy measures.
The system dynamics is determined by the flexibility of the ligand during the docking
process. The flexibility of the molecule is defined by the rotatable bonds in the
ligand such that changes occurring in those bonds produce all possible molecular
conformations for each ligand.
Although docking models usually evaluate the energy by using a force field scoring
function as a single objective to optimize the interaction between the molecules,
the model proposed in this work is based on the idea that “non-covalent bonds
are critical for maintaining the three-dimensional (3D) structure of large molecules
such as proteins and nucleic acids” [57] and that non-covalent bonds can stabilize
unusual conformations in small ligands when they are bound to a receptor; causing
a detriment in the internal energy. Therefore, as a natural consequence, a multi-
objective optimization approach was chosen to predict protein–ligand structures
(here called complexes), where the objective functions to be optimized were the
non-bond and bond energy terms.
This document is organized in the following chapters:
Chapter 2 explains the cycle of drug design and gives an overview of in silico methods
used in drug design (or computational drug design tools).
Chapter 3 provides a general explanation of the methods that have been proposed
to solve the docking problem.
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Chapter 5 describes each of the five steps that were followed to develop the model:
the definition of the binding site, selection of the molecular representation methods,
application of the scoring function, exploration of the search space and evaluation
of the results.
Chapter 5 contains the experimental framework, which includes the complexes, ex-
periments and measures used to evaluate the proposed method. Additionally, it
presents the results obtained with the proposed method. Finally, the document
presents the conclusions and perspectives for future works in Chapter 6.
Chapter 2
BACKGROUND: THE DRUG DESIGN CYCLE
The development of new molecules for the treatment of known diseases is of special
interest for life sciences. In general, the task of discovering a new drug molecule
is considered as a cycle where several experiments at different levels (in vitro, in
vivo, in silico, etc.) are carried out to select pharmacologically active molecules
that have reduced side effects or can be administered in smaller dosages. The cycle
begins with the identification of an illness and its pathophysiological study (steps A
and B in Figure2.1); it includes the study of the molecular processes underlying the
development of the disease and, ideally, the characterization of the most important
receptors involve in such illness (stage C in Figure 2.1).
This work will focus on developing tools for evaluating candidate drug molecules
when the receptor is known. The receptor will be a structure inside or outside the
cell, whose interaction with exogenous or endogenous molecules (ligands) can alter
biochemical cascades associated with the disease of interest. Receptors can include
DNA, RNA or proteins; but the drug design cycle focuses largely on proteins because
they are the most common type of receptors found in living organisms. Besides, some
proteic receptors are specific for many biochemical pathways, hence, if the function
of the proteic receptor is altered by binding of an exogenous ligand, it is possible to
find molecules with specific pharmacological activity on such receptor (drugs) and
therefore reduce some side effects, which is why the study of proteins involved in
pathological processes is essential for the development of new drugs.
5
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Once the target receptor involved in the biochemical pathway to be affected is char-
acterized, a new drug begins to be searched within a large amount of molecules
(stage G in Figure 2.1). These initial molecules could be of diverse origins, for ex-
ample, they could be compounds extracted from natural sources, synthetic products
or compounds resulting from combinatorial chemistry processes.
To have a more clear idea about the large size of the search space, lets consider
an example proposed by Oprea [59] with the molecules explored for the discovery
of Enalapril, a prominent pro-drug angiotensin converter enzyme (ACE) inhibitor.
Given the parameters as outlined in the patent covering Enalapril (see Figure 2.2),the
author estimated the total number of compounds included in the generic claim for
Enalaprilat, its active ingredient. The compound in the patent is described in Figure
2.3. “where the substituents R2 and R7 are hydrogens and R6 is a hydroxyl group;
R and R3 are described as lower alkoxy groups, for example methyl, ethyl, isopentyl,
and similar radicals; R1 is described as a substituted lower alkyl, which corresponds
to a phenyl group; R4 and R5 are described as being lower alkyl groups, which
may be linked to form a cyclic 4- to 6-membered ring in this position. According
to these parameters, the number of compounds included in the patent gets close to
1.72 × 1013 (more than 17 trillion compounds)” (Taken from Tudor Oprea, 2005,
Chemoinformatics in Drug Discovery) [59].
Figure 2.2: Structure of Enalapril
Figure 2.3: Enalapril. Simplified structure
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In this kind of search spaces, it is necessary to answer some questions in order
to reduce the number of compounds, for example: What is the binding affinity
between the different ligands and the studied receptor? Which chemical and physical
features of the ligand will determine the biological activity? How will the absorption,
distribution, metabolism and elimination of the drug be? Is it possible to predict the
toxicity of a specific molecule? Finding the answers to these questions is important
as they allow to narrow the initial number of lead molecules to about 10 compounds
with the desired characteristics, called drug candidates. In Figure 2.1, this process
lies between the identification of lead molecules and drug candidates (stage C and D,
respectively). Assays to select molecules at the first stages of the cycle are expensive
in terms of money and time, therefore drug developers have introduced software tools
and simulations of biological systems to reduce the number of in vivo and in vitro
assays and so enhance the amount of resources invested to obtain a new drug. In
fact, some new drugs such as b-inhibitors[5] and hypocholesterol drugs have been
developed thanks to in silico methods and therefore their use and development have
been adapted as another useful tool in the cycle of drug design.
Once the drug candidates are selected and synthesized, they enter pre-clinical and
clinical trials to select the one that has the best pharmacological profile (stage E in
Figure 2.1); this molecule is then registered and approved for use and commercial-
ization. An important aspect in the development and research for new drugs is that
the process does not end once a molecule is released to the public; on the contrary,
it is still kept under study in order to establish adverse drug effects, undesirable un-
known interactions with food and other drugs, safety profile in specific ethnic groups
and other possible pharmacological uses. The results obtained at this stage of the
cycle most of the times lead to the conclusion that the molecule could be modified
by increasing its selectivity for the receptor in order to obtain a better safety profile
or decrease the dosage. Also, molecules derived from other commercially available
drugs can be used as lead molecules in a new drug design cycle and follow the same
process described above.
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2.1 IN SILICO METHODS
As mentioned in the above section, in silico drug design methods have been adapted
as an important tool in the drug design cycle. Since this work focuses on the de-
velopment of a new in silico drug design method, it is important to consider their
advantages and disadvantages compared to other methods:
• Saving time in the process of obtaining new drug candidates.
• Decreasing the cost of in vivo and in vitro experimentation.
• Decreasing the use of animals in experimentation.
• Predicting unknown ligands that could interact with the receptor under study.
On the other hand, some of the disadvantages are:
• Inability to predict the toxic effects of a ligand.
• Impossibility to predict undesirable interactions with concomitantly adminis-
tered drugs. Some studies have been conducted to establish whether drugs and
food are metabolized through the same pathway; however, it is not possible to
determine all the possible interactions of a specific molecule [11, 26, 76, 6].
• Although it is possible to find a ligand with high binding affinity for a receptor,
this does not guarantee that such ligand would have any type of biological
activity because there are still other important issues, such as its absorption,
distribution, metabolism and elimination, to be taken into account.
The application of in silico methods to drug design can be summarized in two types
of models (see Figure 2.4):
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• Models of biological systems when information about the structure
of the receptor is not available. In this type of methods, although infor-
mation about the receptor is not available, there is a set of molecules known
to have the desired pharmacological activity and based on which molecules
with similar activity can be hypothesized. A research group at the University
of Washington has dedicated some efforts to extract information and develop
tools to produce molecules when structural information about the receptor is
not available [17]. This approach is called the Pharmacophore-Based Virtual
Screening
• Models of biological systems when information about the structure
of the receptor is available . In the early eighties, two groups headed by
Goodford [34] and Kuntz [52] , repectively, lead the development of techniques
when the 3D structure of the receptor was known. Goodford and colleagues not
only developed the use of probe atoms and chemical groups to map the binding
site, but also identified the optimal binding sub-sites; this was a prelude for
positioning and assembling fragments to build a new molecule [73, 74]. On
the other hand, the studies by Kuntz and colleagues have proposed the major
innovations for exploring the formation of possible complexes, even including
approaches under solvation conditions [82].
Figure 2.4: In silico methods
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2.1.1 DRUG DESIGN WITHOUT KNOWN RECEPTOR
PHARMACOPHORE
A pharmacophore is a subset of pharmaceutically relevant molecular descriptors,
which are potential key points for the interaction of the ligand with the receptor
[15]. The success of studies on pharmacophores have motivated efforts to extend
the domain to non-congeneric series where the structural similarity between active
molecules in the same bio-assay is not obvious. Certainly, the studies by Beckett
and Casey on opioids to define those parts of the active molecules (pharmacophoric
groups) that are essential for the pharmacological activity were of seminal impor-
tance for this type of models [7]. Kier and Aldrich [50] further developed the con-
cept of pharmacophore and applied it to rationalize the Structure Activity Relation
(SAR) of several systems. These methods are undergoing continuous development.
In general, they are intended to generate a pharmacophore hypothesis by finding
molecular characteristics associated with a biological effect. These characteristics
are found by considering several drug molecules with similar known biological ac-
tivity and overlapping their structures, seeking to detect similarities between their
chemical groups, such as for example in hydrogen bond donors and acceptors, aro-
matic rings, etc.
2.1.2 DRUG DESIGN WITH KNOWN RECEPTOR STRUCTURE
If the 3D structure of the receptor involved in the disease of interest is known
and the binding site(s) has been identified and characterized, both geometrically
and physicochemically, it is possible to tackle drug design from two points of view:
by constructing the structure of a new molecule with high binding affinity for the
receptor (de novo design) or by searching in some databases for molecules with
ability to bind to the receptor (docking) (See Figure 2.4); this latter approach is the
one explored in this work and will be explained in detail in the next chapter.
Chapter 3
BACKGROUND: DOCKING
Molecular docking aims to predict the structure of receptor–ligand complexes, being
the receptor usually a protein and the ligand a small organic molecule [13]. Since
the development of combinatorial chemistry, molecular docking has been applied to
aid in the design of combinatorial compound libraries (large collections of chemical
compounds obtained by combinatorial chemistry) and their in silico pre-screen to
identify potential new drugs[13]. In the earlier studies, docking was successfully im-
plemented in drug design as a tool to search drug compound databases and optimize
lead candidates; nowadays, docking programs are used to prioritize molecules for in
vivo or in vitro assays.
The first docking programs allowed automating methods to search for molecular
complexes with geometric and chemical complementarities. To simplify the search
and reduce the degrees of freedom, protein and ligand structures were considered
as rigid bodies, except with respect to translation and rotations. Also, the atoms
of both the receptor and the ligand were explicitly expressed and simple scoring
functions were applied. Since the prominent works by DesJarlais [24], who used a
simple approach with some of the ligand’s degrees of freedom, several algorithms
have been developed to explore molecular flexibility. When more degrees of freedom
are added to the system, a larger number of potential protein–ligand complexes can
be explored, thus increasing the likelihood of finding compounds with high binding
affinity for the receptor. This is reflected as an increase in the effectiveness of the
proposed methods.
12
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Any method proposed for solving the docking problem has to deal with the following
aspects [13] (Figure 3.1):
1. Definition of the binding site.
2. Selection of the molecular representation method.
3. Implementation of scoring functions.
4. Exploration of the search space.
5. Evaluation of the similarities between the predicted structures.
Each one of these aspects will be explained briefly below.
3.1 DEFINITION OF THE BINDING SITE
As shown by the first box in Figure 3.1, the binding site can be characterized by its
geometric and physicochemical properties.
Geometric Aspects
Several approaches have been developed to define the geometric features of the
binding site; CAST, PASS, POCKET and SURFNET are some of such methods
[56, 39, 55, 53]. These methods are shown in the Figure3.2.
CAST (See figure 3.2A) represents atoms in the protein’s binding pocket as spheres;
centers in the spheres are linked with the other centers to obtain triangles. If three
contiguous triangles do not pass through the atoms and one of them is obtuse, it is
possible to say that a binding site is defined [56].
In PASS, the protein surface is covered by virtual spheres. Additional layers are
located over the surface in an iterative process, until the spaces are filled in. In
Figure 3.2 D, the binding sites are depicted as black points.
POCKET and LIGSITE are methods that identify pockets by using a series of simple
operations on a cubic grid. Both libraries start by generating a regular Cartesian
CHAPTER 3. BACKGROUND: DOCKING 14
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grid. To start, all grid points are labeled as solvent and set to a value of 0; grid points
that are inaccessible to the solvent are assigned a value of −1. As a straightforward
method for this steric validation, distance checks are conducted to see whether a
solvent molecule centered at a grid point overlaps with any atom of the protein
[39, 55].
In the SURFNET approach, which is shown in Figure 3.2B, a sphere is placed
between the van der Waals surfaces of a pair of atoms. The radius of this gap sphere
is then reduced until it is not penetrated by any of the neighboring atoms. All the
resulting final gap spheres are stored and compute to describe the shapes and sizes
of the protein cavities [53]. Similar approaches can be found in [41] and [69].
Figure 3.2: Cavity identification methods
These images were taken from Huang et al. 2006 [42]
Physicochemical Aspects
In addition to the need of defining the shape of the binding site, it is also necessary
to characterize its physicochemical environment in order to determine the binding
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affinity between both molecules. One of the first approaches to this task was pro-
posed by Goodford in 1985. Figure 3.3 shows the result of applying this approach to
phospholipase A2 (protein) and a water molecule (probe molecule). This approach
computes the interaction energy of both molecules and gives an array of energy val-
ues, which define a contour where the interaction between the probe and the protein
would be most likely to take place (dark region in the middle of Figure 3.3). Some
other approaches are closely related to this idea [36, 23, 51, 77, 90, 84, 18, 9, 32].
One of the most interesting ones is the approach proposed by Trovov and Abagyan
[4], who also used the idea of forming contours in order to recreate the volume and
shape of the binding site.
Figure 3.3: Contour defined by physicochemical interactions
The structure used in the calculation was the phospholipase-A2 macromolecule in interac-
tion with water molecules in a region that should have an interaction energy of -9 kcal/mol.
The image was taken from the work reported by Goodford in 1985 [34].
3.2 MOLECULAR REPRESENTATION
An important problem for developing computational tools for drug design is the
molecular representation. A molecular representation should allow introducing and
manipulating data of molecular structures on a computer so as to obtain useful
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results for the drug design process. Several methods have been proposed to represent
a molecule, but in general terms, they are all closely related to the problem to be
solved. For example, problems related to searching for conserved regions in a protein
can be solved by using sequence information, which is a molecular representation
with low level of detail, but if the problem involves calculating the binding energy,
a more detailed molecular representation is necessary.
Taking into account the level of detail, molecular representations could be seen
as implicit (compact) and explicit (detailed). Compact representations such as the
SMILES format, which represent the molecule as a string of characters by specifying
atoms and bonds, have the advantage of reducing the quantity of data needed to
represent a molecule. However, information about atom localizations in the 3D
space and the presence of hydrogens are lost in this type of representations. On the
contrary, explicit representations do include atom types and their respective bonds
with the other atoms. They have different levels of detail depending on whether
atoms and bond types, presence or absence of hydrogen atoms are specified, so they
can be adjusted to improve the exploration of the conformational space. However,
such improvement causes an increase in the quantity of data needed per molecule.
Since both aspects, detail and quantity of the data, are always in conflict, a wide
spectrum of approaches ranging from very compact to highly detailed has been
proposed.
Specifically for the docking problem, different methods have been formulated, among
which the ones proposed by Kuntz et al., DesJarlais et al. and Rarey et al. [24,
54, 71] are some of the most outstanding ones. These methods represent the ligand
as a composition of rigid parts in which each part is separately matched within
the docking site without assuming dependence on the order in which the ligand
fragments are placed.
The representation method proposed by Smillie et al. is based on clique finding,
which is an NP-complete problem where each atom is considered as a vertice and
covalent bonds as edges of the graph[83].
In the approach proposed by Mitzutani et al., the molecular reconstruction is done
based on energetically favorable docking models by considering only the formation
of hydrogen bonds between heteroatoms in the ligand and the protein receptor. The
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position, orientation and conformation of the ligand are defined by the distances
between hydrogen atoms in the ligand and hydrogen atoms in the protein receptor
with ability to form hydrogen bonds [62].
The method proposed by Sandack et al. is based on an extension and generalization
of the Hough transform and the geometric hashing paradigms for rigid object recog-
nition. In this method, both molecules (the ligand and the receptor) are represented
as sets of outstanding points, which represent their molecular surfaces. With these
surfaces it is possible to screen a database of known ligands (models) for all ligands
showing substantial partial surface complementarity to the receptor surface, without
colliding with the receptor [78].
Goodsell and Olson employed the Metropolis method to search for ligand conforma-
tions and combine it with energy evaluations; this approach considers that molecular
representations should allow changing each degree of freedom of the rigid body (the
receptor), such as the translation and rotation, and also include the degree of free-
dom of each torsion angle of the ligand [35].
3.3 EXPLORATION OF THE SEARCH SPACE
Once the appropriate molecular representation method(s) has been defined, it is
necessary to explore the 3D space defined by the binding site and the conformations
that this ligand could adopt in the search space. The exploration of the search space
is important because the structures of some drug candidate molecules are unknown
and the stable conformations that they would adopt in the binding site of a specific
receptor are different from the ones they appear to have when they bind to other
structures in vacuum.
According to a classification of the different approaches to explore ligand conforma-
tions in the binding site proposed by Kuntz et al. [13], the algorithms employed for
conformational searches can be classified into one of the following three categories:
systematic, stochastic and deterministic.
3.3.1 SYSTEMATIC APPROACHES
In systematic searches, the exploration is done based on the values associated to each
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degree of freedom and each of these values is explored in a combinatorial fashion. As
the number of degrees of freedom increases, the number of evaluations increases too.
To deal with this problem, some constraints are introduced to prevent the algorithm
from exploring zones that can give wrong solutions.
Incremental Construction or Fragment-based
Generally, these methods divide the ligand into rigid and flexible pieces; rigid sections
are defined between rotatable bonds. One rigid part is chosen by the method;
particularly the fragment with less possible anchor positions. The number of anchor
possibilities is denoted as n and it will determine the number of branches of the
search tree. At the next level, the method selects the next fragment with the lowest
anchor position possibilities and so on, until all the fragments have been included.
Some of these methods take into account chemical interactions in order to reduce
the number of anchor possibilities [71].
Some programs and approaches have introduced incremental construction (fragment-
based) methods as an alternative to explore the conformational space. Examples of
such methods are: DOCK 4.0[27], FlexX[71], LUDI [10], ADAM [63], Hammerhead
[95], SLIDE [79] and SPECITOPE [80].
3.3.2 DETERMINISTIC APPROACHES
These methods look for molecular conformations with low energy in such a way that
the current states are closely related to the immediate previous conformations in a
deterministic way. One important problem of deterministic methods is that they
are prone to get trapped in local minima.
Molecular Dynamics (MD)
Explorations based on molecular dynamics work basically by setting a trajectory to
explore the protein surface; however, one of the biggest problem with this kind of
methods is that an MD trajectory will become often trapped in a local minimum and
will not be able to step over high energy conformational barriers [13][88]. Moreover,
they are extremely dependent on the initial state of the system, which makes it
necessary to execute the process many times changing the initial conditions in order
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to explore the whole protein surface and all the molecular conformational options.
This increases the time demanded to explore the conformational space, making it
very expensive in terms of time and computational resources. Examples of this kind
of methods are AMBER [19] and CHARMM [14].
3.3.3 STOCHASTIC METHODS
Search algorithms based on stochastic methods make random changes, usually by
changing a degree of freedom at once, guiding these changes by a scoring function
that will allow the search to converge to good solutions. This kind of methods
overcome the drawbacks of deterministic methods; however, they may have some
convergence problems.
Monte Carlo Methods
Standard Monte Carlo (MC) methods or Metropolis MC [61] consider the ligand
as a whole. The position of the molecule is changed by random translation or
rotation movements. Some implementations also include changes in rotatable angles,
making it possible to explore and evaluate different molecular conformations. In
these methods, ligands are usually placed randomly at the binding site, and changes
are made randomly. The resulting ligands are evaluated and those with the lowest
energy are chosen for the next cycle [13]. Early implementations of AutoDock [31]
[33] used MC simulations; MC methods are also implemented in the program ICM [1]
[2] and the MCDOCK package, which makes part of the DOCK program developed
by Kuntz’s group. Others examples are QXP [3, 45], GLIDE [47, 28], PRO LEADS
and prodock [52].
Genetic Algorithms
Generic Algorithms are also probabilistic search procedures, which are designed to
work on large spaces involving states that can be represented as strings. The basic
idea of genetic algorithms was developed in 1960 by Holland [40]; he presented
the genetic algorithm concept as an emulation of the biological evolution and gave a
theoretical framework for adaptation under the genetic algorithm. Holland’s Genetic
Algorithm evolves a population of “chromosomes” , which are strings that represent
solution samples distributed on the search space, driven by a kind of natural selection
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together with genetic-inspired operators of crossover, mutation and inversion. Figure
3.4 illustrates the model. The operators used in this kind of algorithms can be
described as follows:
Figure 3.4: General diagram representation of a genetic algorithm cycle
(a) Reproduction cycle
A. B.
(b) A. Crossover and B. Mutation Operators
Figures were taken from Dilvan de Abreu Moreira, 1995 Agents: A Distributed Client/Server
System for Leaf Cell Generation
• The selection operator tends to choose the most fitted chromosomes such that
the selected chromosomes will produce in average more offspring than the less
fitted ones.
• The crossover operator exchanges parts of two chromosomes in a similar way
as the biological recombination between two single chromosomes does.
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• The mutation operator makes random changes on the values at some locations
in the chromosomes.
• The inversion operator reverses the order in which genes are arranged; how-
ever, this operator is not commonly used.
In summary, Genetic Algorithm methods should have at least the following elements
• A population of chromosomes.
• Evaluation and selection according to fitness.
• Crossover to produce new offspring.
• Random mutation.
Genetic algorithms have been used on several docking programs such as GOLD [46]
and AutoDock [65], just to mention a few examples.
3.4 SCORING FUNCTIONS
Scoring functions are used as the objective functions to guide the docking process
and to help evaluate the different kinds of conformations and locations that could
be acquired by the ligand in the binding site; this kind of functions should allow
selecting the most promising structures from the whole set of possibilities.
Ideally, scoring functions should estimate the binding energy between macromolec-
ular receptors and small organic molecules in a fast way; a task that many of them
have achieved. However, they should also calculate accurate binding free energies,
but no scoring function has come even close to that [81].
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There are important disadvantages in all scoring functions. All of them calculate the
binding affinity as a sum of independent terms; hence, their complexity depends on
the number of terms. Many of them disregard entropic effects because they evaluate
interactions between a rigid receptor and a ligand in a single, frozen binding mode,
and they also ignore specific solvation and desolvation effects.
In spite of the problems mentioned above, many scoring functions have been widely
used in docking models with successful results. In general, docking models use differ-
ent kinds of scoring functions and make it possible to obtain a consensus result[93].
Typically, they attempt to optimize the prediction results yielded by the docking
programs, but they do not provide a better understanding of the protein–ligand in-
teraction. Therefore, scoring functions are selected based on the specific conditions
of the problem at hand. Also, discussions about which scoring function is most suit-
able for a particular system are often difficult when the 3D structure of the complex
has not been experimentally observed [68]. In consequence, a blind combination of
some arbitrary scoring functions would not necessarily lead to better results [93] ,
which is why the optimization of energy predictions is still an important field of
work in docking models.
Scoring functionsused in docking could be classified into three categories: force fields,
empirical scoring functions, and knowledge-based. Each of these categories will be
explained below.
3.4.1 FORCE FIELDS
Force field scoring functions have been developed using physical principles. Since all
possible molecular interactions between a receptor and biologically interesting small
organic molecules could be represented and optimized with different levels of detail
and information, a wide range of force fields functions has been developed.
The first simulations of molecular interactions did not include explicit information
on the molecules (such as atomic data) or excluded parameters such as the solvent,
which is where the molecular interaction takes place, mainly because computer
power was limited. Weiner et al. proposed one of the earliest force field scoring
functions[94], even before the interaction of complex molecules could be simulated
in an explicit solvent [20]. As computer power increased, it was possible to obtain
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more realistic simulations, such as the one proposed by Jorgensen and co-workers,
who proposed explicit solvent representations [48].
In a simplistic model, force field functions could be represented as shown in Equation
2, where (a) terms of bond and angles, which are represented by a simple diagonal
harmonics (these terms are generally taken from reported experimental structure
determinations), (b) Torsion parameters, which define the dihedral angles between
atoms , (c) van der Walls terms, which are represented by 6–12 potentials and (d)
Electrostatic interactions modeled by Coulombic interactions, which are taken from
quantum calculations or empirical determinations[19]. (a) and (b) are energy terms
related to bond atoms, while (c) and (d) are energy terms related with non-bond
atoms.
Epair =
∑
bond
kr(r − req)2 +
∑
angles
kθ(θ − θeq)2︸ ︷︷ ︸
(a)
+
∑
dihedral
vn
2
× [1 + cos(nφ− γ)]︸ ︷︷ ︸
(b)
+
∑
i<j

Aij
R12ij
− Bij
R6ij︸ ︷︷ ︸+
(c)
qiqj
εRij︸ ︷︷ ︸
(d)

3.4.2 EMPIRICAL
Empirical scoring functions calculate the binding energy as a weighted sum of explicit
hydrogen bonding and hydrophobic contact terms. Hydrogen bonds are described
by distant terms and angles, and the binding affinity is defined by the deviation
of distances and angles from idealized hydrogen bonding geometries. Additionally,
these terms are weighted by the Ki (dissociation constants), typically obtained from
the experimental assays reporting the protein–ligand structure.
Some of the empirical scoring functions used in docking models are DrugScore [84]
and SuperStar [90].
3.4.3 KNOWLEDGE-BASED
This kind of energy functions were proposed as an answer to the massive increase
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of structures in the protein data bank (PDB)1. These functions are built exclusively
from statistical analysis of the complex structures that have been experimentally de-
fined to date. They are based on the assumption that shorter inter-atomic distances
between atoms with favorable interactions occur more often than average, whereas
unfavorable interactions occur less frequently.
First, atom types must be defined on the ligand and the protein receptor; then when
this problem has been resolved, the distances and frequencies between the different
atom types can be established. Knowledge-based functions assume that repulsions
are interactions that will not be present in the reported structures.
Thus, score values typically consist of hundreds of small contributions, which makes
it difficult to interpret the results. An example of knowledge-based scoring functions
is the one developed by Gohlke et al. [33] and Muegge [66].
1 http://www.pdb.org
Chapter 4
AN EVOLUTIONARY APPROACH TO THE DOCKING PROBLEM
As explained in Chapter 2, the following are the the tasks that a solution to the
docking problem must consider:
1. Definition of the binding site.
2. Selection of the molecular representation method.
3. Exploration of the search space.
4. Implementation of the scoring function.
The way in which the proposed method tackled each task will be explained in detail
in this chapter.
4.1 DEFINITION OF THE BINDING SITE
The characterization of the binding site allows defining the environment where the
ligand will accomodate and its conformation in such space defined in the receptor.
In the proposed method, the definition of the binding site will focus on the geomet-
rical aspects, while the physicochemical properties (what anchor the ligands bind
26
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to the binding site) will be evaluated by the scoring function. The geometric char-
acterization begins by identifying the receptor surface; this reduces the number of
possible places where to find cavities in the receptor molecule, since it is shown as
a compact structure and not as a cluster of points (atoms) in the space. Once the
receptor surface has been determined, it is possible to define the number of cavities
in the protein, as well as their size and volume.
In the method postulated in this work the molecular surface of the receptor is cal-
culated taking into account the approach proposed by Richards in 1977 [72]; who
defined the molecular surface using van der Waals radii. According to this approach,
each atom in the molecule is represented by its x, y and z coordinates, which repre-
sent the atom’s center and van der Waals radius. These values are use to generate
potential spheres and the sum of these spheres yield a molecular surface. Figure 4.1
illustrates Richards’ approach for calculating a molecular surface.
Figure 4.1: Receptor Surface.
In this figure, the first line that binds the circles (which are the receptor atoms
represented in two dimensions), defines the van der Waals surface. Image taken
from Richards, 1977 [72].
Richards’ proposal allows to define all the cavities in the receptor, including those
to which solvents have no access to. This could be seen as an advantage because it
defines cavities that are not available to the solvent when the molecule is crystallized,
but that could be available at some moments during the normal functioning of the
protein. An example of a protein surface obtained according to Richards’ method
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is shown in Figure 4.2. The surface was calculated using the DMS program1, and
the graphics were generated using Chimera2; both of which were developed by the
University of California, San Francisco (UCSF).
Figure 4.2: Surface of the Human Immunodeficiency Virus-1 Protease
(PDB ID: 1aaq).
A. The protein is represented by the bonds shown in white while the calculated surface
is shown as a red contour.
B. The calculated surface is the result of the sum of the van der Waals radii.
C and D. Even cavities located inside of the protein, which are not accesible to the
solvent, are identified by Richards’ method.
1 http://www.cgl.ucsf.edu/chimera/docs/UsersGuide/midas/dms1.html
2 http://www.cgl.ucsf.edu/chimera/
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Figure 4.3: 2D Example of sphere generation over a surface
It should be noted that even though this method identifies cavities within the pro-
tein, it does not provide information about the shape and size of such cavities,
nor it chooses in which binding site to evaluate the small organic molecules during
the docking process. To overcome this issue, geometric complementarity tools have
been implemented, among which one of tools that has shown better results is the
sphgen cpp tool used by the DOCK program [52]. This program generates a nega-
tive image of the receptor surface by placing spheres over the surface. Each sphere
touches the molecular surface at two points and has its radius along the surface
normal vector, as shown in Figure 4.3. The spheres are calculated over the entire
surface, so that there is approximately one sphere per surface point. The represen-
tation obtained with the spheres is then filtered to keep only the largest spheres
associated with the receptor atoms. A clustering algorithm is then applied to the
filtered set to generate the negative image of the receptor surface and clusters are
then ordered according to the number of spheres, which will correspond to the size
of the cavity. Since the clusters could be located in different places over the recep-
tor, the binding site where the ligand will be docked is selected according to the
localization of the ligand that was reported in the elucidation of the protein–ligand
complex structure. The cluster that defines this binding site is also used to define
the receptor zone to be explored . Figure 4.4 shows the cavity selected as a binding
site for the example shown in Figure 4.2.
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Figure 4.4: Cavity selected on the Human immunodeficiency virus-1 Pro-
tease
4.2 SELECTION OF THE MOLECULAR REPRESENTATION METHOD
In docking, molecular representations must deal with two important aspects: the
localization of the ligand with regards to the protein and the conformations that it
can adopt during the binding process. The localization of the ligand with respect
to the protein is solved by representing both in the same coordinate system and
limiting its location to the area defined in the identification of the binding site; this
helps to reduce considerably the vast search space to a specific area in the protein.
Conversely, the ligand conformations could be seen as combinations of rotatable
bond angles. Therefore, the degrees of freedom depend on translations and rotations
over the x, y and z axes and the dihedral angles defined by the number of rotatable
bonds in the molecule.
The localization of the ligand in the binding site is computed using the same co-
ordinate system and explicitly stating the locations of the atoms by their x, y and
z coordinates. Changes resulting from translations and rotations of the molecule
are reflected as changes in the coordinates of all the molecule’s atoms. However,
exploring the different conformations of the molecule is not an easy task, the first
available algorithms considered fragments of molecules or molecular groups with
ability to establish specific bonds, as opposed to considering only dihedral angles,
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which would make the exploration of the search space easier. Besides, algorithms
that use representations based on information about rotatable bonds and dihedral
angles are most commonly applied to proteins in which information about bond
distances, bond angles and torsion angles can be limited to the twenty amino acids
that conform them. In this work, an algorithm was implemented based on this idea
so that different data representation methods could be alternated to simplify the
exploration of the search space.
Some of the molecular representations that can be easily interchanged are shown in
Figure 4.5. Each has its own advantages and disadvantages, as explain below.
Algebraic Representations
In algebraic representations, such as the one shown in Figure 4.5(a), three coordi-
nates (x, y and z ) are computed for each atom, which is the most straightforward
method of representing a molecular structure. With this method the potential en-
ergy function can be expressed, evaluated, or minimized when a structure has been
defined in terms of Cartesian coordinates. Moreover, structural or dynamics changes
are described in terms of atomic coordinates as well [75].
Geometric Representations
An example of a ggeometric representation is presented in Figure 4.5(b). These kind
of representations are based on the inter-atomic distances between pairs of atoms in
the molecule. Its main advantage is that some inter-atomic distances, such as for
example distances between covalently bonded atoms, are reported by experimental
structure determinations. Therefore, it is possible to reconstruct a molecule when
all the distances between the atoms have been reported [75].
Trigonometric Representations
Trigonometric representations rely on the idea that molecules can be represented
by angles and distances. The main advantage of this type of representation is that
few data is needed given that bond distances and bond angles are constant, and
therefore it is only needed to represent dihiedral angles to re-construct a molecule
(see Figure 4.5c) [75].
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Probabilistic Representations
Probabilistic representations use entropy methods as a tool to reconstruct the elec-
tron density function based on X-ray crystallographic techniques [75].
Figure 4.5: Data representation of molecular structures
4.2.1 MOLECULAR REPRESENTATIONS USED BY THE PRO-
POSED METHOD
Of the four types of interchangeable representation methods described above, the
docking model proposed in this work uses an algebraic and a trigonometric repre-
sentation. Both representations have their own advantages and therefore are con-
veniently alternated during the docking process according to the specific needs of a
particular stage.
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The trigonometric representation allows expressing the molecule in terms of torsion
angles, which causes a significant reduction in the amount of information needed to
represent a molecule. With this type of representation, it is easier to make changes in
the ligand’s molecular conformations so as to identify which ones bind more stably
to the receptor. In addition, this representation can be more easily manipulated
by the genetic algorithm used in the proposed approach, as it will be explained in
Section 4.4 (Exploration of the search space) .
To represent a molecule, the relevant torsion angles needed are those formed between
the four atoms that are involved in a rotatable bond. For example, to obtain a
trigonometric representation of the molecule shown in Figure 4.6, the amount of
necessary data is equal to the number of rotatable bonds, and their corresponding
dihedral angles g1, g2, and g3. The worst case occurs when the molecule is exclusively
composed by atoms with single bonds; however, in this case the number of rotatable
bonds is always significantly lower than the total number of atoms.
This highlights an important aspect about the trigonometric representation: it de-
pends on the number of rotatable bonds in the molecule, which is no cause for
concern in the case of proteins and nucleic acids (RNA and DNA) because their
structures are limited to a few, relatively small, known amino acids or nucleotide
bulding blocks given that the number of possibilities are vast and difficult to delimit.
In an algebraic representation, atoms are represented in an explicit way and the
necessary data is larger than the data of the trigonometric representation. For
example, the number of data needed to obtain an algebraic representation of the
molecule shown in Figure 4.6, is equal to the x, y and z coordinates of each of its
21 atoms and the explicit description of each covalent bond. The level of detail
of an algebraic representation can increase, for example, by discriminating between
atom types, not only according to their hybridization state but also by the atoms
that they are bond to, as well as by specifying the type of covalent bond formed
between them, not only depending on whether it is single, double or triple, but also
specifying the chemical group in which it is established (e.g. amido, amino, carboxyl
and aromatic groups). This was an important aspect to consider for the purpose of
this work given that the higher the level of detail, the better the evaluation of the
receptor–ligand complex made by the scoring function would be.
CHAPTER 4. AN EVOLUTIONARYAPPROACH TO THE DOCKING PROBLEM34
Figure 4.6: Comparison between the trigonometric and algebraic represen-
tations of a molecule
The violet circles represent the 21 atoms in the molecule. The blue lines represent
the rotatable bonds and the white lines are non-rotatable bonds. In the algebraic
representation, it is necessary to make explicit all atoms and bonds, while in the
trigonometric representation only dihedral angles are requiered.
Although data manipulation at the computational level becomes more complex with
an algebraic representation, the evaluation stage of the proposed docking method
becomes easier and better results are obtained with this representation.
4.2.2 ALTERNATING BETWEEN MOLECULAR REPRESENTA-
TIONS
As explained above, a trigonometric or an algebraic representations are necessary
at specific stages of the proposed docking method. For this reason, the alternation
between the two representations was an important aspect to consider in order to
perform an efficient search and evaluation of the molecules.
Both the ligand and the receptor are input to the program as algebraic representa-
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Figure 4.7: Atom types, bonds, rotatable and non-rotatable bonds.
Acording to the conditions established for defining a rotatable bond, the molecule in
the figure has three rotatable bonds, which are represented in blue. Although the bond
represented in green is a single bond, it is one of the exceptions described in the text since
it belongs to a methyl groups. The orange bond is an example of a non-rotatable bond, as
it is established between carbons with sp2 hybridization and belongs to a ring. The violet
circles correspond to the atoms that are involved in such bonds, their hybridatizations are
noted together with the atom symbol. For example, a carbon with sp2 hybridization is
denoted as C-sp2.
tions, but at different stages of the algorithm the ligand’s algebraic representation is
replaced by its trigonometric representation. For this purpose, the proposed method
implemented an algorithm to perform an automatic and relatively fast alternation
between the algebraic and trigonometric representations. This algorithm is based
on the studies performed by Dong and Wu [25] on proteins, but applied to small
organic molecules.
4.2.2.1 FROM THE ALGEBRAIC TO THE TRIGONOMETRIC REP-
RESENTATION
To alternate between the algebraic and the trigonometric representations, the al-
gorithm first defines the number of rotatable bonds in the small organic molecule.
These bonds are defined using the tool developed by Kairys 3, which makes it pos-
sible to distinguish between rotatable and non-rotatable bonds based on the defi-
3 http://www.ccl.net/cca/software/PERL/Find Rotatable Bonds/index.shtml
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nitions made by Makino, Kuntz [58] and Hanser et al. [38]. Rotatable bonds are
mainly defined by the atom types involved in the bond. Basically, rotatable bonds
could be single bonds; those formed by atoms with sp3 –sp3 and sp3 –sp2 hybridiza-
tions. Some other bonds , such as those established between sp2 –sp2 atoms (double
bonds), and sp3 –sp3 atoms present in a ring, could be considered as rotatable, but
they are excluded since the flexibility of these bonds is limited. If it is necessary to
explore the different conformations resulting from rotating some of the bonds that
were excluded, the conformations must be previously generated and each molecule
must be treated as unique. Additionally, terminal bonds, such as bonds between
carbon-hydrogen atoms and methyl groups, are not considered as rotatable bonds
by the proposed method. Some examples of atom types, bonds, and rotatable and
non-rotatable bonds are illustrated in the molecule shown in Figure 4.7.
Once both of the atoms involved in a rotatable bonds are identified, two contiguous
atoms have to be considered to calculate the dihedral angle. For example in Figure
4.8, the dihedral g1 angle is computed using the information on the four contiguous
atoms depicted in violet. In the same way, the dihedral angles g1, g2, and g3
are computed for each rotatable bond in the molecule to obtain a trigonometric
representation of the molecule.
Accordingly, dihedral angles are computed using Equation 4.1; Figure 4.9 shows the
vectors and angles needed for such computation.
cosαijkl =
(axb)(axc)− (axc)(bxb)
‖a‖ ‖b‖2 ‖c‖ sinαijk sinαjkl
(4.1)
4.2.2.2 FROM THE TRIGONOMETRIC TO THE ALGEBRAIC REP-
RESENTATION
The transformation from the trigonometric to the algebraic representation is done
according to the method proposed by Dong and Wu [25]. The molecular recon-
struction is performed by computing the localization of a fourth atom, based on the
information about the coordinates, distances, bond angles and dihedral angles of the
three previous atoms. An example of this is explained in Appendix 1.
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Figure 4.8: Dihedral angles in a molecule
Atoms 1, 2, 3 and 4 are defining the planes (represented in blue) for calculating the dihedral
angle. The rotatable bonds in that molecule are expressed by g1 , g2 , and g3 .
Figure 4.9: Planes, vectors and angles used for the calculation of dihedral
angles.
The four atoms involved in the rotatable bond are represented by x i x j, xk, x l; each bond
is noted by vectors a, b and c; the angle formed between vectors a and b is named aijk,
the angle formed between b and c is named ajkl. Finally, the calculated angle is the one
defined by the normals to the planes formed by the four atoms, which is named aijkl.
Information regarding distances, bond angles and no-rotatable dihedral angles are
considered constants and therefore are stored based on the algebraic representation
of the molecule. On the contrary, variable data such those regarding dihedral an-
gles from rotatable bonds are expressed in the trigonometric representation. Since
changes in the dihedral angles of rotatable bonds are propagated in the molecule to
atoms that are directly or indirectly involved in the bond; these changes are regis-
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tered in a new algebraic representation. An example of this situation is presented
in Figure 4.10. If g3 is rotated, the atoms highlighted in pink will adopt a new ori-
entation based on the angle specified in the trigonometric representation. However,
if the change is produced in g1, all the atoms highlighted in blue will have a new
orientation. Although in this example only changes in one direction are considered,
it is possible to introduce changes in any direction.
Therefore, it is possible to represent any conformation of a molecule by computing
the localization of the fourth atom based on the information of the three previous
atoms (see Appendix 1 ).
Since the proposed method can produce stable and unstable molecules, the scoring
function is used to evaluate the viability of such predicted stuctures.
Figure 4.10: Atoms affected by changes on dihedral angles of the rotatable
bonds
Atoms highlighted in pink are affected by changes in g3, while changes g1 are re-
flected in atoms highlighted in blue.
4.3 IMPLEMENTATION OF THE SCORING FUNCTION
Energy functions are used to guide the search for molecules with the ability of bind
to protein receptors based on the evaluations and assignment of scores that will
allow to differentiate between stable and unstable protein–ligand complexes.
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An energy function based on the force field was chosen as the scoring function. This
function includes data from both quantum chemistry calculations and experimen-
tation, in the specific case of this work, it allows to evaluate energy of both large
molecules (DNA, RNA and proteins) as well as of small organic molecules. It is
worth noting that computations based on quantum chemistry are more accurate
than the experimental ones, but the former are computationally more expensive.
However, evaluations performed by force field scoring functions are not necessarily
closely related to the experimental results and the same occurs even with other types
of scoring functions. Some successful docking programs have used scoring functions
based on the force field to evaluate molecular complexes [27, 46].
In general, energy functions based on the force field assign scores to the evaluated
molecules by adding energetic terms from the molecules involved in the system [91].
The molecules can be of different kinds, including small organic molecules, proteins,
DNA, RNA or solvent, just to mention few. Each term in Equation 4.2 is computed
by considering all the atoms involved in the system.
We can describe the energy as a sum of bond and non-bond energetic contributions
(see Equation 4.2). Bond terms refer to the molecule’s internal energy and they
include covalent bonds (bonds), bond angles (angles) and torsion angles (dihedrals),
while non-bond terms are related to interactions where no covalent bonds are estab-
lished but electrostatic attractions or repulsion forces are presented: they include
van der Wall forces, which are represented by the term (
Aij
R12ij
− Bij
R6ij
), and Coulomb
forces represented by the term (
qiqj
εRij
).
Epair =
∑
bonds
kr(r − req)2 +
∑
angles
kθ(θ − θeq)2+
∑
dihedral
vn
2
× [1 + cos(nφ− γ)] +
∑
i<j
[
Aij
R12ij
− Bij
R6ij
+
qiqj
εRij
]
(4.2)
Bond terms could be seen as hard and soft parameters. Hard parameters are
bonds and bond angles, and their values are obtained from experimental data of
the reported structures. They generally consist of a reference value and a range
where it can fluctuate; deviations from the reference value are penalized by an
unfavorable score. In contrast, torsion angles are considered as the soft parameter
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because they could be influenced by non-bond terms; however, they are also obtained
from experimental data and are modeled by a harmonic function were the rotatable
angle could vary between 0 and 360 degrees, with minimizations made by quantum
chemistry calculations.
Reference values deteminated from experimentation change according to the type
of atoms involves in the bonding, such that the distance between atoms of carbons
with sp2 hybridization (C=C) is not the same as the distance between carbon atoms
with sp3 hybridization (C-C). The same phenomenon occurs with bond angles where
three atoms are involved, or torsion angles where four atoms are interconnected. A
higher discrimination of atom types allows a better approximation of the energy
values predicted by the Force Field Scoring Function to energy values obtained
by the experimental studies. As in the molecular representation, in small organic
molecules atoms are not limited to just a few types, compared to macromolecules
such as proteins and nucleic acids (RNA and DNA), and therefore they cannot be
easily discriminated.
We used the atoms types defined by the Amber Force Field developed by UCSF
University [19] and its expansion to small organic molecules [91] was used. Atom
types were assigned by the antechamber program [92], while those that were not
assigned by the program were determined by taking into account: the atoms symbol
(for example C, O, H, N, P, etc.), hybridization, and neighbor atoms.
The reference values to assign the atom types of the protein receptor were taken from
AMBER [19], while reference values for the ligand were obtained from GAFF [91].
However, it may happen that some reference values were not present, especially, in
the case of ligands. In such cases, the reference values were taken from those which
had the nearest atom type array. For example, if the reference value for the dihedral
angle formed by the atoms X1-X2-X3-X4 has not been determined experimentally
and therefore reported in GAFF [85], the values for X1-X2-X3-X5, where X5 has
the same atom symbol and hybridization of X4, would be considered instead.
Non-bonding terms referred to any kind of interactions occurring without the
existence of covalent bonds. These interactions could be established by electric
charges of ions, partial atom charges, and atomic radii that produce repulsion when
two atoms collide. The calculation of the attraction or repulsion due to electric atom
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charges is done according to the Coulomb law, while attraction or repulsion forces
due to the atoms’ radii are calculated according to the Lennard–Jones potential
function [34].
The radii of the atoms were taken from either the AMBER or GAFF force fields de-
pending on whether the evaluated molecule was a protein or small organic molecule.
These values were used to calculate the score of attraction or repulsion due to the
van der Waal terms considered in Equation 4.2.
The partial atomic charges, which are employed to calculate electrostatic attractions
or repulsions, as expressed in Equation 4.2, can be computed according to different
methods; however, there is no consensus about which is the best method to ob-
tain them. In this work, a widely used method based on atomic connectivities was
adopted. This method was introduced by Gasteiger [29] and its calculation is rela-
tively fast compared to the calculations based on quantum chemistry; such as with
the AM1-BCC method [43]. In small organic molecules a partial charge valuesmust
be calculated for each atom of a new input molecule, whereas in organic macro-
molecules partial charge values are initially assigned for each of the atoms of the
21 amino acids (in the case of proteins), and therefore do not have to be calculated
everytime a new proteins is introduced, which greatly simplifies calculations.
Generally, the scoring functions that are used to evaluate complexes protein–ligand
give unique energy values; However, as explained before, it is possible to consider
those values as terms that evaluate different aspects of the molecule: the internal
energy, which is determined by the bonding terms, and the external energy, which is
defined by the non-bonding terms. These two terms could be in conflict when there
are two or more molecules interacting in the same system; for example, in vacuum a
molecule takes a particular conformation that is stable under such conditions; here
bond and non-bond terms have different weights compared to when the molecule is
interacting with other molecules and therefore could adopt different conformations,
which are stabilized by non-bonding interactions.
4.4 EXPLORATION OF THE SEARCH SPACE
The docking problem will thus be considered as a multi-objective optimization prob-
CHAPTER 4. AN EVOLUTIONARYAPPROACH TO THE DOCKING PROBLEM42
lem, unlike the typical search approaches which focus on the optimization of a single
objective function and look for the molecule with the best energy score. Such en-
ergy values are obtained from a scoring function, which evaluates the molecular
complexes. Only recently, multi-objective optimization began to be applied to the
solution of bioinformatics or computational biology problems [37].
The multi-objective approach is implemented in the proposed method to deal with
the conflicting terms in the energy function. It does not consider the energy func-
tion as a unique value, but instead it optimizes both energy contributions from the
bonding and non-bonding terms. Although the docking problem can have other ob-
jectives that could be optimized, such as geometric complementarity, the proposed
model will only consider the bonding and non-bonding terms.
4.4.1 MULTI-OBJECTIVE OPTIMIZATION
A multi-objective optimization is an appropriate approach to the solution of prob-
lems where one or more optimal solutions may arise when several objectives are
considered. Typically, the objectives are estimated very differently and are often
conflicting aspects of the solutions [75].
In general, a multi-objective optimization problem (MOOP) can be defined as fol-
lows:
Definition 3.1 Multi-Objective Optimization Problem:
Finding a vector x = [x1, x2, ..., xn]T which:
i) Satisfies the r equality constraints, such that hi(x) = 0, 1 ≤ i ≤ r;
ii) Is subject to the s inequality constraints gi(x) ≥ 0, 1 ≤ i ≤ s;
iii) and optimizes the vector function z = f(x) = [f1(x); f2(x), ..., fm(x)]
T
According to this definition, the MOOP focuses on finding the optimal values for
the vector x (in the space of variable decisionsX), that minimizes/maximizes the
function f(x) (in the objective space Z). This optimization process is carried out
by taking in to account that the constraints h and g need to be satisfied. The vector
x is an n -dimensional decision vector in the X space, and z = f(x) is an objective
vector that maps X into Rm, where m is the number of objectives to be optimized.
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Figure 4.11: The n-dimensional parameter space maps to the m-
dimensional objective space.
The image of X in the objective space is the set of all attainable points Z (See
Figure 4.11)
The optimal set of solutions is defined using the concept of dominance, which is used
to compare two solutions.
Definition 3.2 Dominance. A vector solution x is said to dominate a solution x,,
denoted by x ≺ x, if zi ≤ z,i,∧,∃i : zi < z,i for 1 ≤ i ≤ m
In other words, x ≺ x,; if the solution x is no worse than x, in all the objectives, and
x is strictly better than x, in at least one objective. Note that if solution x does not
dominate solution x,, this does not imply that x, dominates x. Furthermore, there
are three possible outcomes of this relation: x dominates x,; x is dominated by x,;
or x and x, do not dominate each other.
A Pareto optimal set of solutions X consists of all those vectors that do not dominate
each other, and it is impossible to improve it in any objective without getting worse
results in another objective. Thus a Pareto optimal front can be defined as follows:
Definition 3.3 Pareto Optimum Solution. A solution x ∈ X is said to be a Pareto
optimal solution if and only if there is no x, ∈ X such that x ≺ x′.
There are two aspects that are preserved in the set of solutions that belong to a
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Pareto front: 1) any two solutions non-dominated in the Pareto front must not
be dominated by each other. 2) Any solution that does not belong to the set of
non-dominated solutions is dominated by at least one of the solutions in the set.
It is clear that the multiple solutions obtained in the Pareto front consist of the best
results for the evaluated objectives. However, it is also necessary to have a high-level
decision maker in order to choose the Pareto optimal solution. Figure 4.12 shows the
principles involved in an ideal optimization procedure [22]. Step 1 produces multiple
trade-off solutions, but in the next step, a higher level of information is necessary in
order to choose a final solution.
Figure 4.12: An ideal multi-objective optimization procedure.
Step 1, which includes the optimization process, is illustrated in the first three
boxes. A Pareto front with more than one solution is obtained at the end of this
step; however, in Step 2 the main goal is to obtain one solution from the Pareto
front, which is done by introducing high level information.
Typically, a Pareto front includes a high number of solutions. Therefore, stochastic
methods such as evolutionary algorithms allow to get in one run a set of solu-
tions instead of a single one, unlike classic search algorithms which need of several
runs in order to obtain different solutions. Genetic algorithms mimic natural evo-
lution to perform search and optimization processes to find the best solutions for
a problem. Evolutionary algorithms that deal with multiple objectives are called
Multi-Objective Evolutionary Algorithms (MOEA).
In this work, a MOEA called Elitist Non-Dominated Sorting Genetic Algorithm
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(NSGA-II) was used [22]. Other MOEA are also avaliable in the proposed model,
but NSGA-II is most widely implemented MOEA in diverse kinds of problems. This
is specially useful since the use of MOEAs in biological problems is relatively new
and therefore is not known which MOEA is better for this kind of problems.
4.4.1.1 THE MULTI-OBJECTIVE EVOLUTIONARY ALGORITHM
The NSGA-II algorithm was introduced by Deb. Et al in the year 2000[22]. This
algorithm is based on an elite-preserving strategy and an explicit diversity-preserving
mechanism [75].
Figure 4.13 depicts the NSGA II algorithm. In general, it operates as follows [21]:
• Step 1: Combine parent (Pt) and offspring (Qt) population and create Rt =
Pt ∪Qt.
Perform a non-dominated sorting of Rt and identify different fronts: Fi, i =
1, 2, ..., etc.
• Step 2: Set new population Pt+1 = 0. Set a counter i = 1.
Until |Pt+1|+ Fi < N , perform Pt+1 = Pt+1 ∪ Fi and i = i+ 1
• Step 3: Perform a crowding-sorting procedure and include the most widely
spread (N − |Pt+1|) solutions by using the crowding distance values in the
sorted Fi to Pt+1.
• Step 4: Create offspring population Qt+1 from Pt+1 by using the crowded
tournament selection, crossover and mutation operators.
One of the most interesting aspects of the NSGA-II algorithm is the use of the
crowding distance among the non-dominated solutions, which evaluates the diversity
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Figure 4.13: NSGA II procedure.
of the population. The crowding distance can be calculated either in the objective or
in the variable space. The NSGA-II algorithm was used to find whether the tested
ligand bind to the receptor’s binding site, specifically, to evolve conformations and
locations of the ligand in the binding site of the receptor.
A Java-based framework called jMetal 4 was used in the study and experimentation
of the multi-objective algorithm to solve the docking problem.
4.4.1.2 THE MULTI-OBJECTIVE FORMULATION
In multi-objective problems, it is necessary to define two spaces: the decision space
that represents the set where the solutions would be, and the objective space, where
the set of solutions is represented as a function of the objectives to be optimized.
Also, a set of constrains need to be defined, which will determine the set of feasible
solutions.
Decision space (decision variables). In genetic algorithms, the decision variables
are represented as chromosomes that contain the information of the solutions to the
problem.
In this work, the chromosomes represent conformations and locations of small or-
ganic molecules in the binding site. Particularly, a molecule is represented as an
array of real values that represent the location of the ligand (ID) and the molecule’s
4http://jmetal.sourceforge.net/
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conformation through the dihedral angles of rotatable bonds. Figure 4.14 depicts a
representation of the possible solutions the molecule that appears next to the chro-
mosome representation. It is possible to see in this example that the length of the
chromosome depends on the number of rotatable bonds in the ligand. The operators
over individuals of the algorithm are defined in a similar way to those explained in
Chapter 2, except by mutation in the ID variables. Particularly, in ID, six variables
can be mutated: three for the translation and three for the rotation (over the axis
x, y and z ). However, the number of changes was limited to three when a mutation
in the ID is performed. Moreover, these changes are randomly chosen.
Figure 4.14: Chromosome representation used for the genetic algorithm.
Objective Space (objective functions). In the proposed method, different terms of
the scoring functions are selected to formulate the multi-objective docking problem.
Particularly, two objectives were considered in this work.
According to the energy contributions in the scoring function, the two objectives
were defined as follows: The first objective corresponds to the energy contributions
from the covalent bonds between atoms (bonding terms), such as bonds, bond angles
and torsion angles. The second objective is related to the interactions where a
covalent bond does not exist, such as electrostatic attraction and repulsion forces,
and van der Walls terms. The energy terms for these two terms will be denoted as:
f1 = Ebond
f2 = Enon−bond
Feasible regions (Equality/inequality constraints). The constraints that determine
the feasible solutions in the proposed method are of two kinds: steric constraints
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and limitations to the location of the ligand outside the binding site. The steric
constraints are represented by the collisions between atoms from the same molecule
and with atoms of the receptor. These collisions are penalized by the scoring func-
tion, but are not included within the optimization constraints. On the other hand,
the second type of constraints is related to infeasible locations of the ligand. These
are included by delimiting the binding site, and solutions out of this physical limit
will not be generated.
4.4.1.3 DECISION-MAKING PHASE
The NSGA-II multi-objective algorithm evolves a set of ligands that will bind to a
receptor and yields a set of good solutions based on the selected objectives. However,
it is necessary to include a high level analysis in order to choose one of the solutions
in the final Pareto front. In general, this is a difficult task, specially when the
number of objectives is high and the set of solutions is large.
A proposal made by Branke et al. [12] focuses the selection of the solutions from
the Pareto front on the identification of the knees, i.e., regions in the Pareto front
where small displacements produce a big detriment on at least one of the objectives.
Two methods to find the knees were considered: one based on angles and the other
one based on the utilities.
The angles are defined by two lines that are traced between four points in the Pareto
Front (see Figure 4.15). These angles indicate the presence or absence of a knee.
The larger the angles a, b, g or d are, the higher the probability of classifying the
solution as a knee.
The decision-making process based on the utilities focuses on the cost of choosing
the next best solution. It can be defined as the additional cost that must be accepted
if the best solution is not available and the second best solution is chosen. In this
work, both decision makers (based on angles and utility) were implemented.
4.5 EVALUATION OF THE OBTAINED RESULTS
The proposed approach was tested with molecular complexes reported in PDB . This
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Figure 4.15: Points to define angles a, b, g or d.
The figure shows the four angles (a, b, g or d) computed to define the presence or
absence of keees in the Pareto front. Each box shows the points (or the solutions)
taken into account to define each angle.
method was evaluated using a metric widely used in the prediction of 3D molecular
structures: the root mean square deviation (RMSD).
The RMSD measures the distance between the predicted conformation and the re-
ported structure, such that a value of zero indicates an exact coincidence between
both structures. The RMSD is defined by the following equation 2:
RMSD(a,b) =
√Pn
i=1|rai−rbi|2
n
Though the molecular complexes are superimposed, only the distance between the
atoms of the ligand are taken into account to compare the molecular complexes,
because the receptor is kept fixed and no atom in the receptor changes. Accordingly,
rai and rbi are the locations of the i− th atom of the ligands a and b, respectively.
The RMSD does not depend exclusively on the conformation and location of the
molecule; it is also determined by the size of the molecule and the protein structure.
Therefore, it is not always true that the best alignment has the best RMSD.
In this work, the Superimpose tool included in the set of programs TINKER 5,
developed by the Ponder laboratory, was used. Superimpose calculates the distance
between the atoms of a molecule. It allows to superimpose specific atoms or the
complete structure.
5 http://dasher.wustl.edu/tinker/
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This tool also allows to translate and rotate the molecule, thus minimizing the
RMSD value. Particularly, it produces three RMSD values: RMSD1, which measures
the distances between atom of both ligand structures without inducing changes in
translation or rotation. This gives an idea about the ability of the method to find
the ideal location in the binding site. RMSD2 corresponds to the distance between
atoms after being translated to the same position of the reported atom; this measure
does not give much information about the goodness of method itself. The third value
RMSD, RMSD3, is the result of translating and rotating the ligand in order to obtain
the best possible superposition between the structures, and allows to know whether
the molecular conformations are the same or not.
4.6 FRAMEWORK OF EXPERIMENTATION
This chapter describes the experimental framework followed to evaluate the behavior
of the proposed model. In brief, experiments were carried out on four protein–ligand
complexes (PDB IDs: 1ABE, 1ACM, 1BAF, 1CDG). The performance of the model
was evaluated by considering the divergence between predicted and reported struc-
tures and the results obtained from such comparisons are described and discussed.
4.6.1 MOLECULAR COMPLEXES
The complexes used to evaluate the proposed method were chosen based on the
following characteristics: (1) proteins involve in the complexes have a remarkable
importance in pharmacology, (2) the complex structure is defined with sufficiently
high resolution so as to be suitable for the docking evaluation, and (3) complexes
have been widely used in the evaluation and validation of several of the methods
available to approach the docking problem. The pharmacological relevance of the
complexes is explained in the following paragraphs, while the structural characteris-
tics in regards to number of atoms, rotatable bonds and resolution of the structure
determination method are presented in Table 4.1.
Complex 1ABE has been important for understanding the role of periplasmic pro-
teins in active transport [70]. It is formed by the L-arabinose-binding protein from
Escherichia coli and both α- and β- L-arabinose monomers [70].
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Table 4.1: Data set of complexes
PDB
ID
Protein Ligand L.A. R.B. Method Resolution
(A˚)
1ABE L-Arabinose-
Binding
Protein
L-Arabinose 20 4 X-Ray
Diffraction
1.70
1ACM Aspartate Car-
bamoyltransferase
N -
(Phosphon
acetyl)-L-
Aspartic
acid
26 6 X-Ray
Diffraction
2.80
1BAF Igg1-Kappa AN02
Fab
N -(2-amino-
ethyl)-4,6-
dinitro-N ’-
(2,2,6,6-
tetramethyl-
1-oxy-
piperidin-4-
yl) -benzene-
1,3-diamnine
35 4 X-Ray
Diffraction
2.90
1CDG Cyclo dextrin
glycosyl-transferase
Maltose 45 12 X-Ray
Diffraction
2.00
L.A.: Number of ligand atoms.
R.B.: Number of rotatable bonds.
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The protein in the 1ACM complex, the aspartate transcarbamoylase catalyzes the
reaction between Carbamoyl Phosphate and L-aspartate to form N -carbamoyl-L-
aspartate and inorganic phosphate. The carbamoyl aspartate thus formed proceeds
through the pyrimidine biosynthetic pathway ultimately leading to the formation of
pyrimidine nucleotides [85]. The ligand has been used as an inhibitor of this enzyme
in the treatment of cancer.
Complex 1BAF corresponds to the crystal structure of the Fab fragment of the
murine monoclonal anti-dinitrophenyl-spin-label antibody AN02 forming a complex
with its hapten, which has been solved at a resolution of 2.9 A˚[16].
According to Moriwaki et al.[64], the protein involves in the 1CDG complex is the
Cyclodextrin Glycosyl-Tranferase (CGTase); a monomeric enzyme with a molecu-
lar weight of about 74,500 Da, containing a sequence of amino acids structurally
similar to the a-amylase enzyme. Besides the cyclization reaction, which forms the
Cyclodextrines (CDs), CGTase catalyzes the coupling reaction and the dispropor-
tionation of linear maltodextrins (see [67] and [60]). This reaction opens the ring
structure and exchanges segments of maltodextrin linear chains. Since the discovery
of the CGTase from Bacillus macerans in 1903, the production of this enzyme has
been studied in several bacterial lineages, such as Bacillus elaterium, Bacillus mac-
erans, Klebsiella pneumoniae, and Bacillus stearothermophillus (see[87] and [44]).
Bacillus species are the major producers of industrial enzymes. Various applications
(e.g., in detergents, pulp and paper processing industry) have prompted the isolation
of strains from a variety of alkaline environments as source of enzymes with suitable
activities. Enzymes capable of producing predominantly a particular type of CD can
decrease the costs of downstream purification and hence are commercially valuable
[30].
4.7 ASPECTS TO EVALUATE
The proposed approach was evaluated on the chosen molecular complexes by con-
sidering the following aspects:
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• The behavior of the Pareto fronts at a different number of evaluations in order
to monitor the minimization process of both objectives (bond and non-bond
terms).
• The RMSD1 values of the predicted molecular complexes in different genera-
tions of the genetic algorithm. This was meant to provide a general idea about
the algorithm convergence to molecular complexes similar to the ones that are
experimentally available.
• Comparison of RMSD1 and RMSD3 values along the iterative process. This
gives an idea about the convergence to locations and conformations of the
ligand molecules.
• Frequency histograms of RMSD values at different generations of the genetic
algorithm as a measure of the dispersion and convergence of the proposed
method.
Chapter 5
RESULTS AND DISCUSION
5.1 1ABE
The search is guided by the energy values to minimize the bond and non-bond terms.
The behavior of this minimization process can be observed in Figure 5.1 showing the
convergence of the non-dominate solutions to minimum energy values. In the specific
case of the 1ABE complex, the values obtained at 10,000 evaluations are highlighted
in blue. The figure shows the convergence of both the bond energy objective and
the non-bond objective, which has a higher dispersion in the early evaluations of the
algorithm.
The dispersion of the solutions and their subsequent convergence to precise confor-
mations and locations in the binding site of the experimentally obtained complexes
are measured by the RMSD1 of the structure superposition, and the correlation be-
tween the energy terms at different number of evaluations. This is shown in Figure
5.2. Notice that as the number of evaluations increases, RMSD values tend to zero
at low energy values.
Figure 5.3 shows the minimum, maximum and average RMSD1 and RMSD3 values
after a certain number of evaluations. The average RMSD decreases significantly
as the number of evaluations increases, until finally stabilizing near zero. As shown
in Figure 5.3, the RMSD remains constant after several evaluations; however, the
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Figure 5.1: Complex 1ABE. Changes in the Pareto Front as the number
of evaluations increases.
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number of solutions in this RMSD range decreases with the time and number of
generations, as shown in Figure 5.4.
Table 5.1 shows the RMSD1 values of the solutions selected by the decision maker.
In general, the best solutions were found by the method based on utility for the
1ABE complex. Figure 5.5 shows some of the results, from which it can be observed
that the best location for the ligand was in the binding site because the rest of
the space was occupied by the receptor and so collisions between the atoms would
otherwise had occurred.
5.2 1ACM
The changes in the Pareto front due to the minimization of both objectives are shown
in Figure 5.6. Same as with the 1ABE complex, a faster convergence occurred in
the objective related to the bond terms. In this sense, energy values for the first
evaluations ranged between 4,630 and 4,638 (Kcal/mol) and such variation remained
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Figure 5.2: Complex 1ABE. RMDS and energy values according to the
number of evaluations.
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stable for the last evaluation (between 4,630 to 4,634 Kcal/mol), which means that
the energy value was optimized with less than 20,000 evaluations. In contrast, non-
bond terms showed a larger range of variation in the first evaluations (-9,100 and
-8,200 (Kcal/mol), which decreased considerably for the last evaluation (-9100 to
-8800 Kcal/mol). In conclusion, the convergence was faster for bond terms than for
non-bond terms. .
In spite of the apparent convergence of the Pareto front after 20,000 evaluations,
it is possible to observe in Figure 5.7 that two groups of individuals are formed
at 20,000 evaluations, which are shown as black points between RMSD values of
7–10 A˚ and 12–15 A˚, and energy values around -4,400 and -4,200 Kcal/mol. In
contrast, the desired behavior would be a simultaneous decreasing of RMSD and
energy values, in which a group of complexes with low RMSD and energy values is
to be obtained at the end of the process. The difference between the desired results
and the results obtained with the model could be related to the gap in the energy
values between the reported structure and the structures yielded by the model.
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Figure 5.3: Complex 1ABE. Changes in RMSD1 and RMSD3 values as the
number of evaluations increases.
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The energy value reported for 1ACM is -4,665.67 Kcal/mol, contrary to the range
obtained in the optimization process (see Figure5.7).Therefore, the algorithm needs
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Figure 5.4: Complex 1ABE. Dispersion in RMSD values according to the
number of evaluations.
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Figure 5.5: Solutions established by the proposed method for the 1ABE
complex.
The receptor surface is represented by the red points and the ligand surface is presented
as a solid white body. The defined binding site is represented by the blue box limiting the
area where the ligand could be located.
a higher number of evaluations than those proposed initially to reach the ideal value
of energy, which is clearly lower than the one achieved at 20,000 evaluations.
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Table 5.1: Complex 1ABE. Decision Maker selection at different number
of evaluations of the method.
Evaluations Decision Maker RMSD1 (A˚)
200 Utility 6.1296
Angles 16.1812
500 Utility 0.0000
Angles 0.0000
1,000 Utility 0.0000
Angles 0.0000
1,500 Utility 0.0000
Angles 13.4469
2,000 Utility 14.8077
Angles 0.0000
Figure 5.6: Complex 1ACM. Changes in the Pareto Front as the number
of evaluations increases.
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Figure 5.8 shows that some solutions can get into the binding site but the atoms
may collide, therefore they are penalized with high energy values and the ligands are
located outside the surface where energy values are better. Therefore, it is possible
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that the complex needs of additional constraints in its geometric parameters related
to the definition of the binding site, or modifications in the parameters of the scoring
function that makes it possible for the ligand to get inside closed cavities despite
colliding with the protein. This task would be approach in a future work.
Figure 5.7: Complex 1ACM. RMDS and Energy values according to the
number of evaluations.
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The apparent convergence to high RMSD values when the molecule has not reached
its better conformation, as well as locations expressed as low energy values, could
produce the effect observed in Figures 5.9 and 5.10, where the molecule has found
an apparently stable state, but such stability is not necessarily true, as mentioned
above.
The solutions yielded by the model are not the best ones from an energetic point
of view, as evidenced by comparing RMSD values to those obtained with programs
such as GOLD1 (1.23 A˚) and DOCK2 (1.11 A˚) .
The decision maker was not considered in this example because all the molecules
1http://www.ccdc.cam.ac.uk/products/life sciences/gold/validation/original gold test set/
2http://dock.compbio.ucsf.edu/Test Sets/v5.4 protein summary.html
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Figure 5.8: Solutions established by the proposed method for the 1ACM
complex.
The white surface corresponds to the receptor, the reported ligand is represented by the
pink molecular surface in the middle of the receptor, and the other colored surfaces to
solutions found by the model.
Figure 5.9: Complex 1ACM. Changes in RMSD1 and RMSD3 values as
the number of evaluations increases.
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Figure 5.10: 1ACM Complex. Dispersion in RMSD values according to
the increase in the number of evaluations.
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were located outside the protein cavity. The chemical environment on the site where
the ligands were located by the proposed method is completely different from the
real binding site, which affects the objective related to the non-bond terms as well
as the decision maker, as this latter works with information on Pareto front and
therefore would not be useful to select the best molecule.
5.3 1BAF
The behavior of the 1BAF complex was similar to the one of the 1ACM complex.
The Pareto front converged to low energy values, as shown in Figure 5.12; however,
there was not much correlation between the RMSD1 and the energy (see Figure 5.13).
This shows that the number of evaluations was probably insuficient and, similar to
the case of the 1ACM complex, several atom collisions could have occurred in the
binding site where the molecule is supposed to accommodate, as observed in Figure
5.11, thus reducing the probability of finding molecules close to the binding site, as
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it would be locating the ligands on the protein’s surface regions with low energy
interaction, but far away from the binding site.
Figure 5.11: Solution established by the proposed method for the 1BAF
complex.
The white surface corresponds to the receptor and the magenta surface to the ligand. Other
ligand conformations and locations are represented by atoms and sticks. It is possible to
find molecules near the surface and the binding site, but not inside the binding site. Same
as in the 1ACM complex, there are collisions between ligand and protein atoms due to the
disposition of the binding cavity.
The apparent convergence to high RMSD values when the molecule has not reached
its best conformation, as well as low energy locations, could produce the effect
observed in Figures 5.14 and 5.15, where the molecule has reached an apparently
stable state but has not necessarily reached the best one, same as it occurred with
the 1ACM complex.
5.4 1CDG
As mentioned in the previous complexes, the Pareto front changes with the number
of evaluations to search for the minimum energy values, as shown in Figure 5.16.
In this experiment, the convergence to bond energy terms occurred faster than for
non-bond terms, but less faster than for the previous ligands because the number
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Figure 5.12: Complex 1BAF. Changes in the Pareto Front as the number
of evaluations increases.
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of rotatable bonds was 12, which is considerably higher than the number of rotat-
able bonds in other molecules shown in Table ??. The high number of rotatable
bonds makes it difficult to predict the molecules location and conformation in the
binding site for most of the available methods. However, as seen in Figure 5.17, the
proposed method showed a good performance for predicting both the location and
conformation reported for the 1CDG ligand, which has a large number of rotatable
bonds. Such molecules are represented by a group of low energy solutions and low
RMSD values observed in Figure 5.17. Besides, Figure 5.18 shows that the cavity
in this protein, unlike in 1ACM and 1BAF, does not produce collisions between
atoms of the molecules, making it easier and precise to predict the complex. The
decrease in RMSD values depicted in Figure 5.19 shows that average values decrease
significantly as the number of evaluations becomes larger, until reaching values close
to zero. Although the maximum RMSD values remains constant, the number of
solutions with lower RMSD values increases, as it can be observed in Figure 5.20.
The ability of the algorithm to find adequate conformations and locations for ligand
molecules with a considerable number of rotatable bonds is specially attractive and
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Figure 5.13: Complex BAF. RMDS and Energy values according to the
number of evaluations.
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useful for predictions about protein–ligand complexes, especially when dealing with
ligands that cannot be easily handled by using other approaches.
Table 5.2 shows the RMSD1 values for the solutions chosen by the implemented
decision maker algorithm for different number of evaluations. The table allows to
compare which of the criteria (angles or utility) is the most appropiated one to
select the complex that will be reported to the user. In this specific case, the best
results were selected by the approach that takes into account the angles. This
means that the lowest RMSD structure, at different number of evaluations, would
selected having into account this criteria; however, more experiments with different
complexes are needed in order to justify whether to use angles or utility as the only
criteria to chose the final solution.
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Figure 5.14: Complex BAF. Changes in RMSD1 and RMSD3 values as the
number of evaluations increases.
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Figure 5.15: Complex BAF. Dispersion in RMSD values according to the
increase in the number of evaluations.
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Figure 5.16: Complex CDG. Changes in the Pareto Front as the number
of evaluations increases.
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Figure 5.17: Complex CDG. RMDS and Energy values according to the
number of evaluations.
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Figure 5.18: Solutions established by the proposed method for the 1CDG
complex.
A. B.
Panel A shows the possible solutions that were found by the algorithm. Panel B presents
the complex reported in PDB.
Figure 5.19: Complex CDG. Changes in RMSD 1 and RMSD3 values as
the number of evaluations increases
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Figure 5.20: Complex CDG. Dispersion in RMSD values according to
the increase in the number of evaluations.
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Table 5.2: 1CDG Complex. Decision Maker selection at different number
of evaluations of the method.
Evaluations Decision Maker RMSD1 (A˚)
200 Utility 12.6537
Angles 11.1741
1,000 Utility 13.7963
Angles 7.7924
5,000 Utility 1.0764
Angles 4.1159
10,000 Utility 5.2105
Angles 1.2507
14,000 Utility 1.2241
Angles 5.1728
18,000 Utility 6.7644
Angles 1.0861
Chapter 6
CONCLUSIONS AND PERSPECTIVES
This research contributes to the solution of docking problem by introducing a novel
method for predicting molecular complexes based on a multi-objective approach at
an atomic conformational level.
In fact, this thesis proposes a methodology to tackle the docking problem. It can
be seen as a valuable bioinformatical tool for predicting the formation of molecular
complexes between proteins and ligands. It is important to notice that the imple-
mentation of this methodology was done using some publicly available third-party
software tools as well as some software tools developed as part of this thesis. The
latter software tools allow the exploration of conformational spaces of small organic
molecules as well as of different energy functions (such as CHARM19 and 27, AM-
BER 94, 96, 98 and 99) and different MOEA algorithms (such as NSGA-II, SPEA2,
PAES, PESAII and IBEA) to evolve different protein conformations.
After analyzing the experimental framework, it is clear that the proposed method is
good in specific cases, but to make it suitable for many kind of complexes, further
work would be necessary in order to consider the possibility of introducing heuristic
information to restrict the search space and enhance the efficacy and efficiency of
the algorithm. With respect to this method it can be concluded that:
The method proposed for representing small organic molecules was adequate for the
search of the conformational space because it reduced the number of variables that
needed to be managed by the evolutionary algorithm. The subsequent alternation
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from strings of characters to 3D representations in an efficient way (being able to
obtain molecules in different formats such as xyz, Sybyl or pdb) allowed evaluating
the complexes satisfactorily with the scoring function. Changes in the molecular
representations were possible by the development and implementation of an algo-
rithm during the development of this work, which allowed generating any molecular
conformation. The algorithm to alternate between the molecular representations
was of crucial importance for the different stages of the docking problem.
The scoring function measures the energy of a complex once the binding between
protein and ligand has been established. The approach proposed for small organic
molecules was appropriate for this work since the scoring function found confor-
mations and locations that were stable, although in some specific cases such con-
formations and localization were not ideal. It is important to emphazise that the
correlation between structures and energy was measured as a relationship between
RMSD errors (in Angstroms) and energy (Kcal/mol). Nevertheless, as explained
in Chapter 4, the correlation between both is not clear, specially when the binding
site is a cavity where several collisions between protein and ligand atoms could oc-
cur. This led to the conclusion that further work is needed to consider additional
scoring functions that evaluate the solutions and penalize these collisions in a soft
way and/or the inclusion of geometric constraints to avoid ignoring possible good
locations by allowing the exploration of cavities that are not accessible to the solvent
or whose shapes and sizes produce several collisions between both the ligand and
the receptor.
A multi-objective evolutionary algorithm enable the method to find molecular com-
plexes with 3D structures relatively close to the ones reported for the benchmark
structures. The ability of finding good complexes when the ligand has a high num-
ber of rotatable bonds is of remarkable importance and interest in this kind of
approaches, considering that some of the other available methods have problems
predicting complexes when a ligand with high number of rotatable bonds is consid-
ered. The proposed method found non-dominated solutions near to or inside the
binding site.
Since the objectives to be optimized by the MOEA were based on non-bonding and
bonding interactions, and taking into account that some of the best results were
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found for molecules with a significantly large number of rotatable bonds, it could
be concluded that this kind of interactions are suitable to model the formation of
complexes when the ligands are molecules that can take different configurations due
to the influence of non-bonding forces.
This work presented a novel method to explore the formation of protein–ligand
complexes, which has great impact in the general understanding of the mechanisms
underlying molecular interactions. It would be especially useful in the discovery and
selection of molecules with possible biological activity in drug development based
on in silico techniques. However, additional work is necessary in order to enhance
the performance of the proposed method.
Future work to extend and improve this study may include: enhancing the method’s
ability to predict molecular complexes, evaluating and validating the proposed method,
and exploring different areas were the method could be applied. The proposed
method could be improved by introducing additional aspects such as additional geo-
metric constraints, other energy functions and different multi-objective evolutionary
algorithms.
Due to the high computational cost of the proposed method, it would be useful
to explore the use of some parallelization techniques in order to reduce the time
required to obtain the molecular predictions.
Also, other compounds such as the solvent and other biological ligands can be in-
cluded in the model in order to make the simulation process closer to reality.
Finally, the ultimate goal would be to include the proposed method in a drug design
cycle in order to evaluate its performance for evaluating drug candidates.
Chapter 7
APPENDIX
ANNEXE 1: Calculation of atomic coordinates based on distances,
bond angles and the dihedral angles.
If the atoms correspond to:
xi = (ui, vi, wi)
xj = (uj , vj , wj)
xk = (uk, vk, wk)
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xl =?
And xl can be seen as:
xl = xk + c where c = c1 + c2 + c3
c1 = −‖c‖ cosαiklna
c2 = −‖c‖ cosαjklnb
c3 = ‖c‖ sinαjkl sinαijklnab
na, nb and n ab are vectors which define a new coordinate system based on
the known vectors, which are found according to the following expressions:
na = a/ ‖a‖
nb = b/ ‖b‖
nab = a× b/(‖a‖ ‖b‖ sinαijk)
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